Molecular therapies for cancer represent a groundbreaking shift in the landscape of cancer treatment, introducing innovative ways to specifically target and disrupt the mechanisms of disease at their origins.Recent studies from Harvard’s Department of Chemistry and Chemical Biology highlight the potential of molecular glues and their ability to manipulate protein interactions that are crucial to cancer development.